View Author
Centemero, M.
( M. Centemero)
patient stent restenosi month diabetes in-stent angioplasty revascularization circulation study follow-up artery in-stent restenosis treatment outcome stenting trial table lesion balloon angioplasty 12 months diabetes mellitus sirolimus-eluting group disease segment angiographic balloon analysis sousa multivessel sirolimus-eluting stents implantation therapy procedure 0.001 abizaid death stented angioplasty lumen angiography surgery result vessel mellitu 12- month follow-up intravascular percutaneou in-lesion coll cardiol nondiabete 1 year nondiabetic patients revascularization therapy study heart 12- factor nondiabetic 4 months difference arts trial stent implantation randomized trial randomized stented angioplasty revascularization investigation right event-free risk factor percutaneous transluminal 1 patient artery disease multivessel disease strategy comparison cardiol incidence ultrasound 0.3 brachytherapy
2 Most Recent Publications
|
Sirolimus-eluting stent for the treatment of in-stent restenosis: a quantitative coronary angiography and three-dimensional intravascular ultrasound study
(Article)
Sousa, J.E. Feres, F. Costa, M.A. Sousa, A.G.M.R. Serruys, P.W.J.C. Abizaid, A.C. Mattos, L.A. Centemero, M. Maldonado, G. Abizaid, A.S. Popma, J.J. Pinto, I.M.F. Jaeger, J. Falotico, R. |
2003-01-01
|
|
Clinical and Economic Impact of Diabetes Mellitus on Percutaneous and Surgical Treatment of Multivessel Coronary Disease Patients
(Article)
Sousa, J.E. Costa, M.A. Hugenholtz, P.G. Sousa, A.G.M.R. Hout, B.A. van Serruys, P.W.J.C. Abizaid, A.C. Centemero, M. Abizaid, A.S. Legrand, V.M.G. Limet, R.V. Schuler, G. Unger, F. Mohr, F.W. Lindeboom, W.K. |
2001-01-01
|
